Atrás
Rango del Día
$65.94
$69.02
Rango de 52 Semanas
$35.95
$87.50
Volumen
827,329
Promedio 50D / 200D
$70.95
/
$63.75
Cierre Anterior
$65.30
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 8.1 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | 39.4 | 3.8 |
| Rev Growth 5Y % | 33.9 | 10.0 |
| D/E | — | 0.2 |
Puntos Clave
Revenue grew 33.89% annually over 5 years — strong growth
Net margin of 39.44% shows strong profitability
Generating 702.34M in free cash flow
P/E of 8.05 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 80.62%
Cash machine — converts 102.88% of earnings into free cash flow
Crecimiento
Revenue Growth (5Y)
33.89%
Revenue (1Y)114.51%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROIC223.85%
Net Margin39.44%
Op. Margin49.49%
Seguridad
Debt / Equity
N/A
Current Ratio2.35
Interest Coverage5.63
Valoración
P/E Ratio
8.05
P/B RatioN/A
EV/EBITDA5.84
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 114.51% | Revenue Growth (3Y) | 35.85% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 33.89% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.73B | Net Income (TTM) | 682.64M |
| ROE | N/A | ROA | 23.45% |
| Gross Margin | 95.85% | Operating Margin | 49.49% |
| Net Margin | 39.44% | Free Cash Flow (TTM) | 702.34M |
| ROIC | 223.85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.35 |
| Interest Coverage | 5.63 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 8.05 | P/B Ratio | N/A |
| P/S Ratio | 3.18 | PEG Ratio | -0.03 |
| EV/EBITDA | 5.84 | Dividend Yield | 0.00% |
| Market Cap | 5.50B | Enterprise Value | 5.01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.73B | 806.78M | 937.82M | 698.80M | 538.59M |
| Net Income | 682.64M | -363.30M | -626.60M | -559.02M | -523.90M |
| EPS (Diluted) | 7.78 | -4.73 | -8.37 | -7.79 | -7.43 |
| Gross Profit | 1.66B | 749.38M | 872.34M | 654.12M | 506.27M |
| Operating Income | 856.51M | -302.57M | -439.50M | -447.41M | -374.44M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.91B | 1.71B | 1.90B | 1.71B | 1.94B |
| Total Liabilities | 3.12B | 2.80B | 2.71B | 2.05B | 1.94B |
| Shareholders' Equity | -205.31M | -1.10B | -818.56M | -347.09M | 1.44M |
| Total Debt | 492.28M | 2.47B | 2.23B | 1.46B | 1.27B |
| Cash & Equivalents | 984.65M | 779.71M | 594.00M | 279.83M | 189.72M |
| Current Assets | 2.27B | 1.37B | 1.22B | 693.79M | 954.37M |
| Current Liabilities | 968.43M | 580.98M | 603.10M | 406.24M | 509.35M |